{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:58Z","timestamp":1791566458354,"version":"4.3.4"},"reference-count":56,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2023,1,24]]},"abstract":"<jats:p>The standard of care for the treatment of chronic hepatitis B (CHB) is typically lifelong treatment with nucleos(t)ide analogs (NAs), which suppress viral replication and provide long-term clinical benefits. However, infectious virus can still be detected in patients who are virally suppressed on NA therapy, which may contribute to the failure of these agents to cure most CHB patients.<\/jats:p>","DOI":"10.1128\/aac.01348-22","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T14:01:00Z","timestamp":1671112860000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection"],"prefix":"10.1128","volume":"67","author":[{"given":"Dara","family":"Burdette","sequence":"first","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0412-6404","authenticated-orcid":true,"given":"Anastasia","family":"Hyrina","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Song","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf K.","family":"Beran","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Cheung","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gilmore","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-6271","authenticated-orcid":true,"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8095-2009","authenticated-orcid":true,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Niedziela-Majka","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Medley","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Mehra","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Morganelli","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Novikov","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congrong","family":"Niu","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Tam","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yue","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan M.","family":"Holdorf","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"IV","given":"William E.","family":"Delaney","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becket","family":"Feierbach","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lazerwith","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","volume-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections.","author":"WHO","year":"2021","unstructured":"WHO. 2021. Global progress report on HIV, viral hepatitis and sexually transmitted infections. WHO, Geneva, Switzerland. https:\/\/www.who.int\/publications\/i\/item\/9789240027077."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12210"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9365-4"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305517"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00272.x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2011.33"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50013"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02388.x"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.13"},{"key":"e_1_3_3_12_2","unstructured":"Marcellin P Gane EJ Flisiak R Manns MP Kaita KD Gaggar A Lin L Kitrinos KM Flaherty JF Subramanian M McHutchison JG Janssen HL Buti M. 2014. Evidence for ongoing low-level viremia in patients with chronic hepatitis B receiving long-term nucleos(t)ide analog therapy poster 1861. Abstr 65th Annu Meet Am Assoc Study Liver Dis Boston MA 7 to 14 November 2014."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262516"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.801"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2152"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00082-18"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.06.014"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00067"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00700-z"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00835-18"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00680-17"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00560-17"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006658"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.036"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.023"},{"key":"e_1_3_3_26_2","unstructured":"Gane E Sulkowski M Ma X Nguyen T Hann H-W Hassanein T Elkhashab M Nahass R Chan S Bennett M Park J Jacobson I Bonacini M Ma J Yan R Knox S Stamm L Ramji A Han S-H Ayoub W Ravendhran N Kwo PY Dieterich D Bae H Schiff ER Lalezari J Fung S Yuen M-F. 2021. Viral response and safety following discontinuation of treatment with the core inhibitor vebicorvir and a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg positive or negative chronic hepatitis B virus infection poster 482. Abstr EASL Digit Int Liver Conf 23 to 26 June 2021."},{"key":"e_1_3_3_27_2","unstructured":"Yuen MF Ma X Hassanein TI Kwo PY Ma J Li L Kitrinos K Knox SJ Stamm LM Bae H Sulkowski MS Elkhashab M Agarwal K. 2021. HBV pgRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued NRTI treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study. Hepatology 74. https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/epdf\/10.1002\/hep.32187."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00176-X"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(17)30317-3"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi0261645"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00015a003"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi9604800"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409732102"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0969-2126(01)00237-4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(01)80009-5"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.06.020"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01734-18"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1715"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.01.028"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-5-33"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350701200309"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350501000507"},{"key":"e_1_3_3_43_2","volume-title":"MacSynergy II. Version 1.0. User\u2019s manual.","author":"Prichard MN","year":"1993","unstructured":"Prichard MN, Aseltine KR, Shipman CJ. 1993. MacSynergy II. Version 1.0. User\u2019s manual. University of Michigan, Ann Arbor, MI."},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32479"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169648"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab597"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31850"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i21.2261"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.08.021"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.06.016"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2021.114117"},{"key":"e_1_3_3_52_2","unstructured":"Verbinnen T Talloen W Shukla U Vandenbossche J Biermer M Beumont-Mauviel M De Meyer S Lenz O. 2020. Viral sequence analysis of chronic hepatitis B (CHB) patients treated with the capsid assembly modulator (CAM-N) JNJ-56136379 (JNJ-6379) as monotherapy in the JADE phase 2a study. Abstr AASLD Digit Exp Conf 13 to 16 November 2020."},{"key":"e_1_3_3_53_2","unstructured":"Berke JM Vergauwen K Dehertogh P Verbinnen T Lahlali T Durantel D Vendeville S Stoops B Raboisson P Vandyck K Pauwels P. 2018. Efficacy of JNJ-61758320 (JNJ-8320) a capsid assembly modulator in HBV-infected chimeric uPA\/SCID mice with humanised liver. Abstr 2018 Int HBV Congr."},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.286"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323300"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323153"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00049"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01348-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01348-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T14:04:32Z","timestamp":1674569072000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01348-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,24]]}},"alternative-id":["10.1128\/aac.01348-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.01348-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"2022-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01348-22"}}